メタ情報
| meta description平均長 | 18.56 |
|---|
| OGPありページ数 | 0 |
|---|
| Twitterカードありページ数 | 0 |
|---|
内部リンク分析(Internal)
| ユニーク内部リンク数 | 629 |
|---|
| ページあたり内部リンク平均 | 72.25 |
|---|
キーワード分析(KeywordMap)
ワードクラウド上位
| 語 | 重み |
|---|
| ZOOM | 1 |
| Web | 0.897752 |
| 3F | 0.7 |
| 1F | 0.679421 |
| N11 | 0.366667 |
| j19 | 0.342063 |
| X1F | 0.336585 |
| N1 | 0.334729 |
| Tsukuba | 0.322222 |
| TMC | 0.26644 |
| Forum | 0.258772 |
| N4 | 0.244331 |
| A3 | 0.244331 |
| WEB | 0.240418 |
| N7 | 0.21468 |
| N10 | 0.213152 |
| Seminar | 0.212563 |
| JAK | 0.192334 |
| N6 | 0.173186 |
| N3 | 0.171032 |
| COPD | 0.156131 |
| OATHAS | 0.146599 |
| CKD | 0.14483 |
| SGLT2 | 0.144444 |
| update | 0.144251 |
| Conference | 0.136614 |
| 2F | 0.133333 |
| TSUKUBA | 0.133333 |
| e頏 | 0.13322 |
| uSGLT2 | 0.131353 |
| F30 | 0.131353 |
| CFAX | 0.131353 |
| j18 | 0.131353 |
| HER2 | 0.131353 |
| Breast | 0.128223 |
| IBD | 0.122222 |
| N5 | 0.122165 |
| Cancer | 0.119898 |
| Update | 0.117098 |
| X1 | 0.117098 |
| N12 | 0.112195 |
| date | 0.110902 |
| IBARAKI | 0.106576 |
| Ibaraki | 0.106576 |
| uCOPD | 0.098515 |
| F00 | 0.098515 |
| MSD | 0.098515 |
| Bevacizumab | 0.098515 |
| ASA | 0.098515 |
| Atrial | 0.098515 |
共起語上位
| 語1 | 語2 | スコア | 共起ページ数 |
|---|
| What | new | 3.667989 | 62 |
| A3 | TMC | 2.420084 | 37 |
| Atrial | Fibrillation | 2.401729 | 12 |
| N8 | N9 | 2.398308 | 37 |
| N1 | index | 2.379467 | 44 |
| Breast | Cancer | 2.335454 | 24 |
| CIDP | ECIDP | 2.252277 | 11 |
| Cardiology | Clinical | 2.176373 | 12 |
| Lupus | Management | 2.176373 | 12 |
| N1 | What | 2.145012 | 46 |
| Chronic | Pain | 2.098641 | 8 |
| N1 | new | 2.011139 | 43 |
| drug | therapeutic | 2.010456 | 8 |
| Current | Topics | 2.010456 | 8 |
| conference | future | 2.010456 | 8 |
| better | lower | 2.010456 | 8 |
| Blood | Pressure | 2.010456 | 8 |
| Sleep | summit | 2.010456 | 8 |
| Meet | Specialist | 2.010456 | 8 |
| CIRCUIT | ERE | 2.010456 | 8 |
| N11 | j19 | 1.977194 | 34 |
| EHR | HER2 | 1.891689 | 10 |
| N1 | N9 | 1.850723 | 44 |
| Pressure | Renal | 1.840771 | 8 |
| Physiology | Renal | 1.840771 | 8 |
| ABRIDGE | CIRCUIT | 1.840771 | 8 |
| Breast | Pfizer | 1.809408 | 12 |
| N1 | N8 | 1.791057 | 33 |
| gWeb | 錧IBD | 1.779383 | 9 |
| N8 | What | 1.777031 | 25 |
| F00 | F30 | 1.773875 | 8 |
| Expert | choice | 1.720378 | 8 |
| SGLT2 | uSGLT2 | 1.681533 | 14 |
| EIBD | IBD | 1.641737 | 11 |
| Forum | Tsukuba | 1.636745 | 51 |
| Incretin | future | 1.626993 | 8 |
| Care | Sleep | 1.626993 | 8 |
| New | therapeutic | 1.586928 | 6 |
| Physiology | Pressure | 1.586928 | 6 |
| Bevacizumab | Einitial | 1.574647 | 5 |
| Bevacizumab | Capecitabine | 1.574647 | 5 |
| Bevacizumab | EFOLFOXIRI | 1.574647 | 5 |
| Diabetes | New | 1.550693 | 8 |
| Diabetes | therapeutic | 1.550693 | 8 |
| ASA | E5 | 1.517539 | 5 |
| PECS | https | 1.517539 | 5 |
| PECS | www | 1.517539 | 5 |
| PECS | jpec | 1.517539 | 5 |
| AQR | PECS | 1.517539 | 5 |
| PECS | zoom | 1.517539 | 5 |
被リンク情報
このデータの閲覧には会員登録が必要になります。会員登録